Search research articles
Contact Us
Filters
Showing results (21-30 of 145) with videos related to
Page
of 15
Sort By:
Cancer Treatment Reviews
|
July 24, 2007
Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies
Caroline Tournoux, Xavier Paoletti, Jean-Claude Barbare
Frontiers in Psychiatry
|
December 3, 2021
Corrigendum: Reading, Conducting, and Developing Systematic Review and Individual Patient Data Meta-Analyses in Psychiatry for Treatment Issues
Nadia Younes, Laurie-Anne Claude, Xavier Paoletti
Journal of the National Cancer Institute
|
March 7, 2019
Cumulative Toxicity in Targeted Therapies: What to Expect at the Recommended Phase II Dose
Maria-Athina Altzerinakou, Laurence Collette, Xavier Paoletti
Contemporary Clinical Trials Communications
|
July 25, 2019
An alternative trial-level measure for evaluating failure-time surrogate endpoints based on prediction error
Shaima Belhechmi, Stefan Michiels, Xavier Paoletti, et al.
Journal of Ovarian Research
|
July 22, 2024
External validation of Standardized KELIM and platinum-resistant recurrence scores in patients with advanced epithelial ovarian cancer
Nina Oufkir, Roman Rouzier, Xavier Paoletti, et al.
Journal of the National Cancer Institute
|
January 6, 2021
Re: Clinical Characteristics and Outcomes of COVID-19-Infected Cancer Patients: A Systematic Review and Meta-Analysis
Paul Cottu, Laurence Bozec, Clémence Basse, et al.
Clinical Trials (London, England)
|
September 21, 2019
Sequential or combined designs for Phase I/II clinical trials? A simulation study
Caroline Rossoni, Aurélie Bardet, Birgit Geoerger, et al.
Contemporary Clinical Trials
|
January 31, 2016
Innovations for phase I dose-finding designs in pediatric oncology clinical trials
Adelaide Doussau, Birgit Geoerger, Irene Jiménez, et al.
Pharmaceutical Statistics
|
June 18, 2026
Early Phase Dose-Finding Designs for CAR-T Cell Therapies
Weishi Chen, Pavel Mozgunov, Jimmy Mullaert, et al.
Bulletin Du Cancer
|
December 3, 2016
[New applications for individual participant data meta-analyses of randomized trials]
Béranger Lueza, Benjamin Lacas, Jean-Pierre Pignon, et al.
Page
of 15
Search research articles
Search
Showing results (21-30 of 145) with videos related to
Sort By:
Page
of 15
Cancer Treatment Reviews
|
July 24, 2007
Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies
Caroline Tournoux, Xavier Paoletti, Jean-Claude Barbare
Frontiers in Psychiatry
|
December 3, 2021
Corrigendum: Reading, Conducting, and Developing Systematic Review and Individual Patient Data Meta-Analyses in Psychiatry for Treatment Issues
Nadia Younes, Laurie-Anne Claude, Xavier Paoletti
Journal of the National Cancer Institute
|
March 7, 2019
Cumulative Toxicity in Targeted Therapies: What to Expect at the Recommended Phase II Dose
Maria-Athina Altzerinakou, Laurence Collette, Xavier Paoletti
Contemporary Clinical Trials Communications
|
July 25, 2019
An alternative trial-level measure for evaluating failure-time surrogate endpoints based on prediction error
Shaima Belhechmi, Stefan Michiels, Xavier Paoletti, et al.
Journal of Ovarian Research
|
July 22, 2024
External validation of Standardized KELIM and platinum-resistant recurrence scores in patients with advanced epithelial ovarian cancer
Nina Oufkir, Roman Rouzier, Xavier Paoletti, et al.
Journal of the National Cancer Institute
|
January 6, 2021
Re: Clinical Characteristics and Outcomes of COVID-19-Infected Cancer Patients: A Systematic Review and Meta-Analysis
Paul Cottu, Laurence Bozec, Clémence Basse, et al.
Clinical Trials (London, England)
|
September 21, 2019
Sequential or combined designs for Phase I/II clinical trials? A simulation study
Caroline Rossoni, Aurélie Bardet, Birgit Geoerger, et al.
Contemporary Clinical Trials
|
January 31, 2016
Innovations for phase I dose-finding designs in pediatric oncology clinical trials
Adelaide Doussau, Birgit Geoerger, Irene Jiménez, et al.
Pharmaceutical Statistics
|
June 18, 2026
Early Phase Dose-Finding Designs for CAR-T Cell Therapies
Weishi Chen, Pavel Mozgunov, Jimmy Mullaert, et al.
Bulletin Du Cancer
|
December 3, 2016
[New applications for individual participant data meta-analyses of randomized trials]
Béranger Lueza, Benjamin Lacas, Jean-Pierre Pignon, et al.
Page
of 15